Sponsor pipeline

MavriX Bio, LLC clinical trial pipeline

1 active trials 1 recruiting

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1/2

NCT ID	Title	Condition	Status	Updated
Phase 1/2
NCT07181837	A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome	Angelman Syndrome	Recruiting	2026-07-24

Get alerts when MavriX Bio, LLC's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.